Tonix Pharmaceuticals Holding Corp. (TNXP) stock
TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.94+0.06 (+2.08%)
Close on Nov 17, 2026Market cap $50.42MP/E –Yield –
Tonix Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Tonix Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$152.99M. For fiscal 2025 it was -$99.84M. The highest annual figure on record is -$1.23M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$99.84M | – |
| FY2024 | Dec 31, 2024 | -$60.93M | – |
| FY2023 | Dec 31, 2023 | -$102.00M | – |
| FY2022 | Dec 31, 2022 | -$98.05M | – |
| FY2021 | Dec 31, 2021 | -$75.56M | – |
| FY2020 | Dec 31, 2020 | -$48.57M | – |
| FY2019 | Dec 31, 2019 | -$26.68M | – |
| FY2018 | Dec 31, 2018 | -$23.97M | – |
| FY2017 | Dec 31, 2017 | -$19.13M | – |
| FY2016 | Dec 31, 2016 | -$37.31M | – |
| FY2015 | Dec 31, 2015 | -$42.53M | – |
| FY2014 | Dec 31, 2014 | -$22.84M | – |
| FY2013 | Dec 31, 2013 | -$8.52M | – |
| FY2012 | Dec 31, 2012 | -$5.71M | – |
| FY2011 | Dec 31, 2011 | -$2.64M | – |
| FY2010 | Dec 31, 2010 | -$1.23M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$42.24M | – |
| Q1 FY2026 | Mar 31, 2026 | -$42.32M | – |
| Q4 FY2025 | Dec 31, 2025 | -$39.65M | – |
| Q3 FY2025 | Sep 30, 2025 | -$28.78M | – |
| Q2 FY2025 | Jun 30, 2025 | -$14.83M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.58M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.63M | – |
| Q3 FY2024 | Sep 30, 2024 | -$18.80M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.92M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.58M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.34M | – |
| Q3 FY2023 | Sep 30, 2023 | -$23.39M | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.37M | – |
| Q1 FY2023 | Mar 31, 2023 | -$32.91M | – |
| Q4 FY2022 | Dec 31, 2022 | -$22.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$23.54M | – |
| Q2 FY2022 | Jun 30, 2022 | -$21.17M | – |
| Q1 FY2022 | Mar 31, 2022 | -$31.05M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.45M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.95M | – |
| Q2 FY2021 | Jun 30, 2021 | -$19.11M | – |
| Q1 FY2021 | Mar 31, 2021 | -$21.06M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.91M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.29M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.04M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.33M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.68M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.65M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.71M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.64M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.82M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.89M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.49M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.77M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.93M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.05M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.36M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.79M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.44M | – |
| Q3 FY2016 | Sep 30, 2016 | -$8.39M | – |
See a number that looks wrong?